Christian Weyer, EVP, Research & Development at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,397 shares at $101.65 ($145K) on 2019-11-27, disclosed to the SEC on 2019-12-02.
Open-market sale of $145k ICPT by EVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $101.65 | 1,040 | $106K | 73.1% |
| 2 | $109.16 | 357 | $39K | 26.9% |
| Total | $103.57 avg | 1,397 | $145K | 100% |
| Filing → |
| ICPT | SELL | 2020-01-27 | $136K | — | Filing → |
| ICPT | SELL | 2019-12-30 | $390K | — | Filing → |
| ICPT | SELL | 2019-11-27 | $623K | — | Filing → |